A Study Using a New Ultrasound System to Assess Fibrosis

Overview

About this study

The purpose of this study is to try a new ultrasound technology that may be used to measure the tissue stiffness in fibrosis caused by radiation therapy or lymphedema.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Patients with radiation therapy on neck/breast or patients with lymphedema
  • Presence of fibrosis per the patient's treating MD or therapist
  • age of 18 and above.

 

Exclusion Criteria 

  • Graft versus host disease
  • Scleroderma
  • Prior non-radiation burn to area of interest
  • Open wound in area of interest
  • Cellulitis or other infection in the area of interest
  • Pregnant women 
    • Women of child bearing potential will be asked if they are pregnant. If not sure, a urine pregnancy test will be given to screen the subject at no cost to the subject

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20205731

Mayo Clinic Footer